Press Release
dsm-firmenich announces redemption of €750 million hybrid bond
Kaiseraugst (Switzerland), Maastricht (Netherlands), July 1, 2025
dsm-firmenich, innovators in nutrition, health, and beauty, has decided to call and redeem the €750 million Deeply Subordinated Fixed Rate Resettable Perpetual Loan Notes (the “hybrid bond”) issued on May 27, 2020 (XS2182055009) by Firmenich International SA (the “Issuer”), a direct subsidiary of DSM-Firmenich A.G. The €750 million hybrid bond, with a coupon of 3.75%, is treated as equity under IFRS rules. The Issuer is exercising its right to call and redeem the €750 million hybrid bond at 100 percent of its nominal value plus accrued interest on August 5. Formal notice of redemption in accordance with the terms and conditions of the hybrid bond has been given separately.
For more information, please contact:
dsm-firmenich investor relations enquiries:
Email: investors@dsm-firmenich.com
dsm-firmenich media enquiries:
Email: media@dsm-firmenich.com
About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss company with dual headquarters in Kaiseraugst, Switzerland and Maastricht, Netherlands, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people. www.dsm-firmenich.com
Disclaimer
This press release does not constitute or form part of, an offer or any solicitation of an offer for securities in any jurisdiction. This press release may contain forward-looking statements with respect to dsm-firmenich’s future. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. Elements of this press release contain or may contain information about dsm-firmenich within the meaning of Article 7(1) to (4) of EU Regulation No 596/ 2014 (Market Abuse Regulation). The English language version of this press release prevails over other language versions.
